11 September 2017 - - Waltham, Massachusetts-based detection, imaging, informatics and service provider PerkinElmer, Inc. (NYSE: PKI) has launched the QSight 210 MD system designed to provide routine high throughput quantitation to laboratories, the company said.
The QSight 210 MD system includes tandem mass spectrometry technology designed to enable laboratories to run hundreds of samples per day. It provides a complete workflow, from sample preparation to end result for maximized throughput.
Unique design features include simplicity 3Q MD software that uses a simple three-step process, MSMS Workstation software for simplifying data review and analysis and reducing errors, a self-cleaning mechanism, and remote instrument diagnostics to ensure optimal instrument use.
PerkinElmer's Diagnostics business group focuses on reproductive health, infectious disease testing and genomics offerings for oncology and other molecular tests through its broad range of instruments, reagents, assay platforms and software offerings.
PerkinElmer's team of 9,000 employees help solve critical issues especially impacting the diagnostics, discovery, and analytical solutions markets.
The company provides detection, imaging, informatics, and service capabilities, combined with deep market knowledge and expertise. PerkinElmer reported revenue of approximately USD 2.1bn in 2016; it serves customers in more than 150 countries.